Conditions

Obesity in the US is projected to continue its rise over the next 18 years, extending to 42% of Americans by 2030, and the cost is projected to reach $549.5 billion….

Short sleep on a disrupted schedule — common in shift work — significantly increases blood sugar, setting the stage for obesity and diabetes….

The number of Australian women diagnosed with gestational diabetes is set to rise by 50% with the implementation of the new guidelines….

A resveratrol-like compound found in red wine and fruits could have potential for fighting obesity by blocking fat uptake….

Aaron I. Vinik, MD, PhD, FCP, MACP Eastern Virginia Medical School, Strelitz Diabetes and Neuroendocrine Center Department of Medicine, Division of Endocrinology and Metabolism Norfolk, Virginia USA Topiramate is a structurally novel anti-epileptic drug effective in management of various types of epilepsy and prevention of migraine headaches. A sulfamate substituted …

Walking briskly for an hour every day can cut the effect of genetic tendencies toward obesity in half….

  An emerging body of research suggests that Alzheimer’s disease may be linked to insulin resistance, constituting a third type of diabetes….

Using A1c to catch prediabetes is cost-effective if the threshold for diagnosis is set at 5.7%….

A new study has shown that for people with iron-deficiency anemia, elevated A1c’s may not reflect glycemic parameter.…

The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted overwhelmingly (20 to 2) in favor of approving the obesity drug Qnexa (Vivus, Inc.), a combination of phentermine and controlled-release topiramate. Qnexa could be the first prescription drug for obesity to reach the market since 1999.…